Details for 2016731721

Up to date per 03.04.2026

Actions

Title / Product Name

NUKLEARREZEPTORMODULATOREN (ROR) ZUR BEHANDLUNG VON ENTZÜNDUNG- UND AUTOIMMUN-KRANKHEITEN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2016731721

EP Publication Number

3307734

E-Number

1206548

Language

PCT Number

US16036283

Publication Date

18.04.2018 A

27.11.2019 B1

Registration Date

27.11.2019

AT Publication Date

15.12.2019

Application Date

08.06.2016

Registration Number

Priorities

09.06.2015

PCT/IB2015/001693

20.11.2015

201562257806 P

01.06.2016

201662343905 P

IPC

C07D 405/14 20060101AFI20161221BHEP

Maximum Duration of Protection

08.06.2036

Owner

AbbVie Inc.1 North Waukegan Road North Chicago, IL 60064US

Representative

Kliment & Henhapel Patentanwälte OGGonzagagasse 151010 WienAT

Inventor

ARGIRIADI, Maria, A.15 Sadie Hutt Lane Southborough, MA 01772US

BREINLINGER, Eric, C.54 Hanson Road Charlton, MA 01507US

CUSACK, Kevin, P.115 Jennifer Drive Holden, MA 01520US

HOBSON, Adrian, D.25 Holman Street Shrewsbury, MA 01545US

POTIN, Dominique23 Chemin de Daix 21240 TalantFR

BARTH, Martine20 rue Claude deschault 21380 Asnières les DijonFR

AMAUDRUT, Jérôme30 boulevard Rembrandt 21000 DijonFR

POUPARDIN, Olivia11 promenade du fort 21490 Varios et ChaignotFR

MOUNIER, Laurent3 Route de Savigny 21380 Marsannay le BoisFR

KORT, Michael, E.507 Green Avenue Lake Bluff, IL 60044US